| Schedule of non cash items | |
| | |
| | |
| | |
| |
| | |
Three months ended
May 31, | | |
Nine months ended
May 31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Depreciation | |
$ | 1,909 | | |
$ | 834 | | |
$ | 5,050 | | |
$ | 2,349 | |
| Change in fair value of derivative financial instruments (Note 12) | |
| - | | |
| 197 | | |
| 30,521 | | |
| (1,461 | ) |
| Share-based compensation expense (Note 15) | |
| 722 | | |
| 514 | | |
| 1,802 | | |
| 2,027 | |
| Accretion of provision for reclamation | |
| 34 | | |
| 35 | | |
| 105 | | |
| 106 | |
| Deferred income tax expense (Note 8) | |
| (152 | ) | |
| 924 | | |
| 2,292 | | |
| 2,632 | |
| Accretion of lease liabilities (Note 10) | |
| 83 | | |
| 98 | | |
| 265 | | |
| 256 | |
| Deferred revenue (Note 9) | |
| (4 | ) | |
| (670 | ) | |
| (3,499 | ) | |
| 398 | |
| Accretion of deferred revenue (Note 9) | |
| 4 | | |
| 34 | | |
| 91 | | |
| 230 | |
| Foreign exchange (gain)/losses | |
| (144 | ) | |
| 23 | | |
| (557 | ) | |
| 95 | |
| Financing costs expensed (Note 5) | |
| - | | |
| - | | |
| - | | |
| 953 | |
| VAT impaired | |
| - | | |
| - | | |
| - | | |
| 20 | |
| Other | |
| (108 | ) | |
| - | | |
| - | | |
| 20 | |
| Total non-cash items | |
$ | 2,344 | | |
$ | 1,989 | | |
$ | 36,070 | | |
$ | 7,605 | |